Leader in Antifungal R&DLeader in Antifungal R&DLeader in Antifungal R&DLeader in Antifungal R&D
Overview
R&D
Management & Board
Advisors
Advisor Meetings
Scientific Services
Publications
Careers
Press Releases
Useful Links
Contact Us
Management Board
.
 

Jens Kindtler - M.Sc., EPA, MBA, Chairman of the Board of Directors, Partner BankInvest Biomedical Venture

Jens Kindtler joined BankInvest Biomedical Venture in early 2001. He focuses on corporate transactions such as M&A, licensing, financing, exits and Intellectual Property Rights. [more]


Christopher Wright - M.A., Non Executive Director

Christopher is a director of Merifin Capital Group, a private European investment firm and an advisory director of Campbell Lutyens & Co Ltd, a London based investment bank. [more]


Shane Kelly - Chief Executive Officer.

Shane has extensive experience in financing, operating and managing early and mid size growth companies. [more]


Jeff Edwards - PhD, Non Executive Director

Jeff spent most of his career in the pharmaceutical industry with many years experience of antimicrobial drug discovery, development and registration. [more]


Robert Nolan - PhD, Non Executive Director

Dr Nolan was director of global licensing in AstraZeneca plc, until he retired at the end of 2004. [more]

Richard White - PhD, Non-executive director

Richard has a wealth of experience in infectious disease drug discovery. [more]


F2G Ltd, PO Box 1, Lankro Way, Eccles, Manchester, M30 0BH
Tel +44 (0)161 785 1270 Fax +44 (0)161 785 1273 Email contact@f2g.com